{"id":2954,"date":"2018-06-29T06:30:00","date_gmt":"2018-06-29T06:30:00","guid":{"rendered":"https:\/\/www.xvivogroup.com\/us\/mfn_news\/forandring-av-antalet-aktier-och-roster-i-xvivo-perfusion-4\/"},"modified":"2018-06-29T06:30:00","modified_gmt":"2018-06-29T06:30:00","slug":"forandring-av-antalet-aktier-och-roster-i-xvivo-perfusion-4","status":"publish","type":"mfn_news","link":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/forandring-av-antalet-aktier-och-roster-i-xvivo-perfusion-4\/","title":{"rendered":"F\u00f6r\u00e4ndring av antalet aktier och r\u00f6ster i XVIVO Perfusion"},"content":{"rendered":"<p><span>Till f\u00f6ljd av utnyttjande av teckningsoptioner har antalet aktier och r\u00f6ster i XVIVO Perfusion AB (publ) under juni 2018 \u00f6kat med 212\u00a0000 aktier och r\u00f6ster. Per den 29 juni 2018 finns d\u00e4rmed sammanlagt 26\u00a0402 496 aktier och r\u00f6ster i bolaget.<\/span><\/p>\n<p><span>G\u00f6teborg 29 juni 2018<br \/> Christoffer Rosenblad, CFO<\/span><span>\u00a0<span><br \/>XVIVO Perfusion AB (publ)<\/span><\/span><\/p>\n<div class=\"mfn-footer\">\n<p><span>F\u00f6r ytterligare information, v\u00e4nligen kontakta: <\/span><\/p>\n<p><span>Christoffer Rosenblad, CFO, +1\u00a0720\u00a0616 2101, christoffer.rosenblad@xvivoperfusion.com<br \/>Magnus Nilsson, VD, +46 31-788 21 50, magnus.nilsson@xvivoperfusion.com<\/span><\/p>\n<p><span>F\u00f6r ytterligare information om XVIVO Perfusions verksamhet h\u00e4nvisas till bolagets hemsida, www.xvivoperfusion.com<\/span><\/p>\n<p><span>Denna information \u00e4r s\u00e5dan information som XVIVO Perfusion AB (publ) \u00e4r skyldigt att offentligg\u00f6ra enligt lagen om handel med finansiella instrument. Informationen l\u00e4mnades f\u00f6r offentligg\u00f6rande klockan 8.30 den 29 juni 2018.<\/span><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Till f\u00f6ljd av utnyttjande av teckningsoptioner har antalet aktier och r\u00f6ster i XVIVO Perfusion AB (publ) under juni 2018 \u00f6kat&#8230;<\/p>\n","protected":false},"template":"","class_list":["post-2954","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ca","mfn-news-tag-mfn-ca-shares","mfn-news-tag-mfn","mfn-news-tag-mfn-type-ir","mfn-news-tag-mfn-lang-sv","mfn-news-tag-mfn-regulatory","mfn-news-tag-mfn-regulatory-lhfi"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>F\u00f6r\u00e4ndring av antalet aktier och r\u00f6ster i XVIVO Perfusion - XVIVO<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/forandring-av-antalet-aktier-och-roster-i-xvivo-perfusion-4\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"F\u00f6r\u00e4ndring av antalet aktier och r\u00f6ster i XVIVO Perfusion - XVIVO\" \/>\n<meta property=\"og:description\" content=\"Till f\u00f6ljd av utnyttjande av teckningsoptioner har antalet aktier och r\u00f6ster i XVIVO Perfusion AB (publ) under juni 2018 \u00f6kat...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.xvivogroup.com\/us\/pressreleases\/forandring-av-antalet-aktier-och-roster-i-xvivo-perfusion-4\/\" \/>\n<meta property=\"og:site_name\" content=\"United States\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/forandring-av-antalet-aktier-och-roster-i-xvivo-perfusion-4\\\/\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/forandring-av-antalet-aktier-och-roster-i-xvivo-perfusion-4\\\/\",\"name\":\"F\u00f6r\u00e4ndring av antalet aktier och r\u00f6ster i XVIVO Perfusion - XVIVO\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\"},\"datePublished\":\"2018-06-29T06:30:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/forandring-av-antalet-aktier-och-roster-i-xvivo-perfusion-4\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/forandring-av-antalet-aktier-och-roster-i-xvivo-perfusion-4\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/pressreleases\\\/forandring-av-antalet-aktier-och-roster-i-xvivo-perfusion-4\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"F\u00f6r\u00e4ndring av antalet aktier och r\u00f6ster i XVIVO Perfusion\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/#website\",\"url\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/\",\"name\":\"United States\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.xvivogroup.com\\\/us\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"F\u00f6r\u00e4ndring av antalet aktier och r\u00f6ster i XVIVO Perfusion - XVIVO","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/forandring-av-antalet-aktier-och-roster-i-xvivo-perfusion-4\/","og_locale":"en_US","og_type":"article","og_title":"F\u00f6r\u00e4ndring av antalet aktier och r\u00f6ster i XVIVO Perfusion - XVIVO","og_description":"Till f\u00f6ljd av utnyttjande av teckningsoptioner har antalet aktier och r\u00f6ster i XVIVO Perfusion AB (publ) under juni 2018 \u00f6kat...","og_url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/forandring-av-antalet-aktier-och-roster-i-xvivo-perfusion-4\/","og_site_name":"United States","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/forandring-av-antalet-aktier-och-roster-i-xvivo-perfusion-4\/","url":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/forandring-av-antalet-aktier-och-roster-i-xvivo-perfusion-4\/","name":"F\u00f6r\u00e4ndring av antalet aktier och r\u00f6ster i XVIVO Perfusion - XVIVO","isPartOf":{"@id":"https:\/\/www.xvivogroup.com\/us\/#website"},"datePublished":"2018-06-29T06:30:00+00:00","breadcrumb":{"@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/forandring-av-antalet-aktier-och-roster-i-xvivo-perfusion-4\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.xvivogroup.com\/us\/pressreleases\/forandring-av-antalet-aktier-och-roster-i-xvivo-perfusion-4\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.xvivogroup.com\/us\/pressreleases\/forandring-av-antalet-aktier-och-roster-i-xvivo-perfusion-4\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.xvivogroup.com\/us\/"},{"@type":"ListItem","position":2,"name":"F\u00f6r\u00e4ndring av antalet aktier och r\u00f6ster i XVIVO Perfusion"}]},{"@type":"WebSite","@id":"https:\/\/www.xvivogroup.com\/us\/#website","url":"https:\/\/www.xvivogroup.com\/us\/","name":"United States","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.xvivogroup.com\/us\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news\/2954","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/www.xvivogroup.com\/us\/wp-json\/wp\/v2\/media?parent=2954"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}